Review: taking Mebeverine hydrochloride and Metformin together


Summary

Drug interactions are reported among people who take Mebeverine hydrochloride and Metformin together. This review analyzes the effectiveness and drug interactions between Mebeverine hydrochloride and Metformin. It is created by eHealthMe based on reports of 93 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Mebeverine hydrochloride and Metformin >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Mebeverine Hydrochloride

Mebeverine hydrochloride has active ingredients of mebeverine hydrochloride. It is often used in irritable bowel syndrome. (latest outcomes from Mebeverine hydrochloride 320 users)

Metformin

Metformin has active ingredients of metformin hydrochloride. It is often used in diabetes. (latest outcomes from Metformin 122,704 users)

On Aug, 26, 2016

93 people who take Mebeverine Hydrochloride, Metformin are studied.


Number of reports submitted per year:

Mebeverine hydrochloride and Metformin drug interactions.

Drug effectiveness over time:

Mebeverine Hydrochloride:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Metformin:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 100.0% - (1 of 1 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Mebeverine Hydrochloride:
  • female: 0.0% - (0 of 1 people)
  • male: 66.0% - (2 of 3 people)
Metformin:
  • female: 100.0% - (1 of 1 people)
  • male: 100.0% - (2 of 2 people)

Drug effectiveness by age:

Mebeverine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 1 people)
  • 60+: 50.0% - (1 of 2 people)
Metformin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 100.0% - (2 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • epistaxis
  • rectal haemorrhage
  • encephalopathy
  • hepatic neoplasm malignant
  • rash pruritic
2 - 5 years:
  • dizziness
  • abdominal pain
  • anaemia haemolytic autoimmune
  • aortic stenosis
  • cardio-respiratory arrest
  • circulatory collapse
  • deep vein thrombosis
  • diarrhoea
  • dyspnoea
  • dysuria
not specified:
  • hypoglycaemia
  • renal failure acute
  • pancreatitis acute
  • fall
  • vomiting
  • cerebral haemorrhage
  • headache
  • cerebrovascular accident
  • defaecation urgency
  • angina pectoris

Most common drug interactions by gender *:

female:
  • fall
  • pancreatitis acute
  • cerebral haemorrhage
  • headache
  • vomiting
  • cerebrovascular accident
  • defaecation urgency
  • convulsion
  • essential hypertension
  • facial asymmetry
male:
  • hypoglycaemia
  • renal failure acute
  • epistaxis
  • rectal haemorrhage
  • encephalopathy
  • erythema
  • hepatic neoplasm malignant
  • angioedema
  • blister
  • chest pain

Most common drug interactions by age *:

20-29:
  • pancreatitis
  • abdominal pain upper
  • frustration
  • hepatic steatosis
  • lipase increased
  • pancreatitis acute
  • weight decreased
30-39:
  • hypoglycaemia
  • renal failure acute
  • urticaria
  • hospitalisation
  • stridor
  • wheezing
  • biopsy liver abnormal
  • choking
  • contrast media reaction
  • dysphagia
40-49:
  • pancreatitis acute
  • hepatic steatosis
  • weight decreased
  • chest discomfort
  • erythema
  • haemoglobin decreased
  • headache
  • photophobia
  • pruritus
  • rash
50-59:
  • encephalopathy
  • hepatic neoplasm malignant
  • dyspnoea
  • psoriasis
  • chest pain
  • chronic obstructive pulmonary disease
  • diarrhoea
  • headache
  • infected skin ulcer
  • insomnia
60+:
  • rectal haemorrhage
  • vomiting
  • convulsion
  • essential hypertension
  • facial asymmetry
  • fall
  • cerebral haemorrhage
  • cerebrovascular accident
  • defaecation urgency
  • epistaxis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Mebeverine hydrochloride and Metformin?

Can you answer these questions?

More questions for: Mebeverine hydrochloride, Metformin

You may be interested in these reviews

More reviews for: Mebeverine hydrochloride, Metformin

On eHealthMe, Mebeverine hydrochloride (mebeverine hydrochloride) is often used to treat irritable bowel syndrome. Metformin (metformin hydrochloride) is often used to treat diabetes. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.